Sex‐specific relationship between adult height and the risk of stroke: A dose‐response meta‐analysis of prospective studies

Conflicting evidence exists regarding the magnitude of the association between adult height and risk of stroke, and it is unclear whether this association is different between men and women. The authors carried out a meta‐analysis to assess the sex‐specific effect of adult height on the risk of stroke and its subtypes. Prospective cohort studies reporting sex‐specific risk estimates of height with stroke or reported in a certain sex were included. Summary relative risks for 5‐unit increments in height were calculated using random‐effects, and dose‐response relationships were performed using a restricted cubic spline model. Subgroup analyses, sensitivity analyses, and tests for publication bias were also performed. In all, 20 prospective studies were identified in this study. The summary of relative risks (95% CIs) of stroke for a 5 cm increase in adult height were 0.93 (0.90‐0.95) for men and 0.88 (0.83‐0.93) for women. There was no significant difference in the effect of height on future stroke risk between men and women (Pinteraction = 0.085). There was evidence of a nonlinear association between adult height and stroke risk, with steeper inverse associations at lower level of height, but further reductions in risk were observed at greater heights. Subgroup and sensitivity analyses showed that the significant associations were consistent in most stratifications and with various inclusion criteria. In conclusion, higher adult height was significantly associated with lower risk of stroke in both men and women.

[1]  Si‐Hyuck Kang,et al.  Association between adult height, myocardial infarction, heart failure, stroke and death: a Korean nationwide population-based study. , 2018, International journal of epidemiology.

[2]  Ashutosh Kumar Singh,et al.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.

[3]  Tom R. Gaunt,et al.  Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis , 2015, International journal of epidemiology.

[4]  Atte Meretoja,et al.  Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study , 2015, Neuroepidemiology.

[5]  K. Yamagishi,et al.  Adult height and body mass index in relation to risk of total stroke and its subtypes: the circulatory risk in communities study. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[6]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[7]  H. Bøtker,et al.  Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study , 2014, European Journal of Epidemiology.

[8]  A. Folsom,et al.  Height and risk of incident intraparenchymal hemorrhage: Atherosclerosis Risk in Communities and Cardiovascular Health study cohorts. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[9]  K. W. Davidson,et al.  Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. , 2012, International journal of epidemiology.

[10]  Nicola Orsini,et al.  Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. , 2012, American journal of epidemiology.

[11]  K. Knobloch,et al.  Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. , 2011, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[12]  R. Martorell Physical Growth and Development of the Malnourished Child: Contributions from 50 years of Research at INCAP , 2010, Food and nutrition bulletin.

[13]  M. Woodward,et al.  Adult height and the risks of cardiovascular disease and major causes of death in the Asia-Pacific region: 21,000 deaths in 510,000 men and women. , 2009, International journal of epidemiology.

[14]  F. Rasmussen,et al.  Association of body size and muscle strength with incidence of coronary heart disease and cerebrovascular diseases: a population-based cohort study of one million Swedish men. , 2009, International journal of epidemiology.

[15]  Yun-Mi Song,et al.  Adult height and the risk of mortality in South Korean women. , 2008, American journal of epidemiology.

[16]  Ross J. Harris,et al.  How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis? , 2008, American journal of epidemiology.

[17]  J. Lynch,et al.  Is the association between childhood socioeconomic circumstances and cause-specific mortality established? Update of a systematic review , 2008, Journal of Epidemiology & Community Health.

[18]  H. Ueshima,et al.  Relation of Adult Height With Stroke Mortality in Japan NIPPON DATA80 , 2007, Stroke.

[19]  H. Adami,et al.  Prospective study of body size and risk for stroke amongst women below age 60 , 2006, Journal of internal medicine.

[20]  Hendriek C Boshuizen,et al.  Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. , 2006, American journal of epidemiology.

[21]  Sander Greenland,et al.  Generalized Least Squares for Trend Estimation of Summarized Dose–response Data , 2006 .

[22]  Alice Stanton,et al.  Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study , 2006, Circulation.

[23]  R. Glynn,et al.  Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. , 2005, American journal of epidemiology.

[24]  G David Batty,et al.  Adult socioeconomic position and the association between height and coronary heart disease mortality: findings from 33 years of follow-up in the Whitehall Study. , 2005, American journal of public health.

[25]  Piero Quatto,et al.  Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. , 2004, American journal of epidemiology.

[26]  F. Lampe,et al.  North-South Gradients in Britain for Stroke and CHD: Are They Explained by the Same Factors? , 2003, Stroke.

[27]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[28]  G. Smith,et al.  Adult height and cause-specific mortality: a large prospective study of South Korean men. , 2003, American journal of epidemiology.

[29]  M. Hughson,et al.  Glomerular number and size in autopsy kidneys: the relationship to birth weight. , 2003, Kidney international.

[30]  L. Korst,et al.  Intrauterine growth restriction is accompanied by decreased renal volume in the human fetus. , 2003, American journal of obstetrics and gynecology.

[31]  Douglas G Altman,et al.  Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.

[32]  G. Smith,et al.  Height in young adulthood and risk of death from cardiorespiratory disease: a prospective study of male former students of Glasgow University, Scotland. , 2002, American journal of epidemiology.

[33]  D. Gunnell Can adult anthropometry be used as a 'biomarker' for prenatal and childhood exposures? , 2002, International journal of epidemiology.

[34]  D. Tanné,et al.  Body Height Is Associated With Decreased Long-Term Stroke but Not Coronary Heart Disease Mortality? , 2002, Stroke.

[35]  W. Hoy,et al.  Low birth weight and reduced renal volume in Aboriginal children. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  E. Vartiainen,et al.  Relation of adult height to cause-specific and total mortality: a prospective follow-up study of 31,199 middle-aged men and women in Finland. , 2000, American journal of epidemiology.

[37]  S. Ebrahim,et al.  Adult height is inversely associated with ischaemic stroke. The Caerphilly and Speedwell Collaborative Studies , 2000, Journal of epidemiology and community health.

[38]  Graham Watt,et al.  Height and risk of death among men and women: aetiological implications of associations with cardiorespiratory disease and cancer mortality , 2000, Journal of epidemiology and community health.

[39]  C. Hart,et al.  Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley study in Scotland. , 1999, Stroke.

[40]  K. Rothman,et al.  Birth weight and length as predictors for adult height. , 1999, American journal of epidemiology.

[41]  S. Wannamethee,et al.  Adult height, stroke, and coronary heart disease. , 1998, American journal of epidemiology.

[42]  R. Carleton,et al.  Short stature and cardiovascular disease among men and women from two southeastern New England communities. , 1998, International journal of epidemiology.

[43]  M. Safar,et al.  Influence of body height on pulsatile arterial hemodynamic data. , 1998, Journal of the American College of Cardiology.

[44]  J P Vandenbroucke,et al.  Bias in meta-analysis detected by a simple, graphical test , 1998 .

[45]  E. Arnesen,et al.  Body height, cardiovascular risk factors, and risk of stroke in middle-aged men and women. A 14-year follow-up of the Finnmark Study. , 1996, Circulation.

[46]  J. Manson,et al.  Height and the risk of cardiovascular disease in women. , 1995, American journal of epidemiology.

[47]  S. Greenland Dose‐Response and Trend Analysis in Epidemiology: Alternatives to Categorical Analysis , 1995, Epidemiology.

[48]  J. Manson,et al.  Height and Incidence of Cardiovascular Disease in Male Physicians , 1993, Circulation.

[49]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.